- Home
- PTGX vs TFSL Comparison
PTGX vs TFSL Comparison
Compare PTGX & TFSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PTGX | TFSL |
|---|---|---|
| Founded | 2006 | 1938 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 3.9B |
| IPO Year | 2016 | 2007 |
Fundamental Metrics
Financial Performance| Metric | PTGX | TFSL |
|---|---|---|
| Price | $89.53 | $14.11 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $86.44 | N/A |
| AVG Volume (30 Days) | ★ 898.7K | 550.7K |
| Earning Date | 11-06-2025 | 10-30-2025 |
| Dividend Yield | N/A | ★ 8.01% |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ 0.72 | 0.32 |
| Revenue | $209,217,000.00 | ★ $318,974,000.00 |
| Revenue This Year | N/A | $11.17 |
| Revenue Next Year | $296.47 | $4.08 |
| P/E Ratio | $124.48 | ★ $44.09 |
| Revenue Growth | N/A | ★ 4.70 |
| 52 Week Low | $33.70 | $11.29 |
| 52 Week High | $93.25 | $14.73 |
Technical Indicators
Market Signals| Indicator | PTGX | TFSL |
|---|---|---|
| Relative Strength Index (RSI) | 64.67 | 55.10 |
| Support Level | $83.52 | $13.93 |
| Resistance Level | $90.85 | $14.23 |
| Average True Range (ATR) | 2.63 | 0.27 |
| MACD | -0.33 | -0.00 |
| Stochastic Oscillator | 83.62 | 59.08 |
Price Performance
Historical ComparisonAbout PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About TFSL TFS Financial Corporation
TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.